Sermonix, a Columbus OH-based biopharmaceutical company, raised $40M in Series A3 funding.The round was led by Perceptive Xontogeny Ventures Fund II (PXV Fund) with participation from existing inv... 原文链接
本文新闻来源www.finsmes.com,版权归原作者所有,内容仅代表作者本人观点,不代表企查查的立场。如有任何疑问或需要删除,请联系
kefu@qichacha.com